Furthermore, a 46 HCC cases study showed that activation of MEK1/2, overexpression of ERK1/2, and hyperphosphorylation of ERK1/2 were respectively detected in 100%, 91% and 69% of HCC patients [126]. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.